Variant report
Variant | nsv829468 |
---|---|
Chromosome Location | chr2:77216448-77224533 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MRPL19-4 | chr2:77216947-77217052 | NR_110284 |
2 | lnc-MRPL19-4 | chr2:77216947-77217052 | ENSG00000234653.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186868934 | chr2:77216448-77216449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551123583 | chr2:77216489-77216490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550757108 | chr2:77216503-77216504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75326642 | chr2:77216511-77216512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551761621 | chr2:77216512-77216513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs17040496 | chr2:77216522-77216523 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs368160068 | chr2:77216532-77216533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534145792 | chr2:77216547-77216548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555355891 | chr2:77216562-77216563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191858833 | chr2:77216568-77216569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114284745 | chr2:77216598-77216599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555852720 | chr2:77216623-77216624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115173863 | chr2:77216657-77216658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142166295 | chr2:77216675-77216676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553397132 | chr2:77216689-77216690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536730390 | chr2:77216711-77216712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544269450 | chr2:77216748-77216749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147704322 | chr2:77216761-77216762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150225913 | chr2:77216809-77216810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111458475 | chr2:77216812-77216813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs3057993 | chr2:77216814-77216815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs386647556 | chr2:77216815-77216816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs184329054 | chr2:77216826-77216827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562224569 | chr2:77216887-77216888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529512952 | chr2:77216924-77216925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140774858 | chr2:77216978-77216979 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs555464744 | chr2:77216983-77216984 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs77595770 | chr2:77217015-77217016 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs562983734 | chr2:77217081-77217082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113541427 | chr2:77217114-77217115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144622401 | chr2:77217160-77217161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114814475 | chr2:77217234-77217235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562579046 | chr2:77217247-77217248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34353118 | chr2:77217251-77217252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs72823154 | chr2:77217254-77217255 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs58936967 | chr2:77217266-77217267 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs567411456 | chr2:77217279-77217280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182326432 | chr2:77217289-77217290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10520176 | chr2:77217310-77217311 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs571107229 | chr2:77217311-77217312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185425747 | chr2:77217339-77217340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs13012574 | chr2:77217348-77217349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs147869531 | chr2:77217357-77217358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs572035789 | chr2:77217358-77217359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542231441 | chr2:77217367-77217368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577964405 | chr2:77217371-77217372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556041946 | chr2:77217429-77217430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545368429 | chr2:77217446-77217447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190722964 | chr2:77217488-77217489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369337317 | chr2:77217496-77217497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Epilepsy | 22083797 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77214000-77220400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr2:77214200-77217400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:77220800-77221200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr2:77222800-77224400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr2:77224200-77224400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr2:77224200-77226600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr2:77224400-77225000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr2:77224400-77226800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |